Webinar: Imaging Technology for Cellular Therapies
CIRM / REGENERATIVE MEDICINE CONSORTIUM
Imaging Technology for Cellular Therapies
Presentations from FDA and Leading Experts
Webinar was held May 26, 2011 – see below for slides and video of the event.
Fee: None
Webinar Topic & Agenda
Imaging Technology for Cellular Therapies
- FDA’s perspective on imaging technology
The use of imaging technology in preclinical studies to assess cell fate - Overview of existing and new imaging technology
Potential issues to consider with respect to different methods - Application and translation of animal model imaging to patients
Moderator: Ellen Feigal, MD, CIRM, Vice President of Research and Development
Speakers:
- See the agenda page for the speakers’ presentation slides
- Pakwai (Patrick) Au, Ph.D., Pharmacology/Toxicology Reviewer, Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)
- Joseph Frank, MS, MD, Chief Frank Laboratory and Laboratory Diagnostic Radiology Research, Clinical Center, Adjunct Senior Investigator, National Institutes of Biomedical Imaging and Bioengineering
- Shahriar Yaghoubi, PhD, Chief Scientific Officer, CellSight Technologies, Inc., Visiting Professor, Department of Molecular and Medical Pharmacology, UCLA School of Medicine